Waters (WAT)
(Delayed Data from NYSE)
$386.69 USD
-0.48 (-0.12%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $386.53 -0.16 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$386.69 USD
-0.48 (-0.12%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $386.53 -0.16 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Zacks News
What to Expect from Shutterfly (SFLY) this Earnings Season?
by Zacks Equity Research
Improved operational efficiency and expansion of its range of products is expected to enhance Shutterfly, Inc.'s (SFLY) second-quarter performance, while higher costs might mar the same.
Why an Earnings Beat is Likely for Waters Corp. (WAT) in Q2
by Zacks Equity Research
Waters Corp.'s (WAT) dominant position in the biopharma end markets and thriving sales in emerging markets will likely help it gain traction in the second quarter.
How Waters Corporation (WAT) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Waters Corporation (WAT) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.
Waters Corp (WAT) Up 3.9% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Waters Corp. (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Ranked Momentum Stocks to Buy for May 16th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 16th:
Waters Corp. (WAT) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Waters Corp. (WAT) first-quarter earnings and revenues beat estimates comfortably.
Waters Corp. Boosts Progenesis QI Software with Proteolabels
by Zacks Equity Research
Premium analytical laboratory instrument and software company, Waters Corporation (WAT), recently expanded its Progenesis QI software with the launch of Proteolabels.
Waters Corp. (WAT) Rolls Out New Products at Pitcon 2017
by Zacks Equity Research
Waters Corporation (WAT) unveiled its latest offerings at the Pittcon Conference and Expo, an annual conference and exposition on laboratory science.
Waters Corp (WAT) Up 7.3% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Waters Corp (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters Corp. (WAT) Q4 Earnings Beat on Top-Line Strength
by Shradha Bardia
Waters Corp. (WAT) fourth-quarter 2016 earnings and revenues beat estimates.
Waters Corp. (WAT) Q4 Earnings and Revenues Trump Estimates
by Zacks Equity Research
Waters Corp. (WAT) fourth-quarter earnings and revenues beat estimates comfortably.
Waters Corp. (WAT) Q4 Earnings: Will the Stock Disappoint?
by Zacks Equity Research
Waters Corporation (WAT) is set to report fourth-quarter and full-year 2016 earnings results, before the opening bell on Jan 24.
Waters Rolls Out 4 Preparative SFCs to Boost Torus Column
by Zacks Equity Research
In a bid to fortify its Torus SFC column line, leading laboratory analytical instrument and software company, Waters Corporation (WAT), unveiled four preparative supercritical fluid chromatography (SFC) columns.